Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial

Written By Angeliki Angelidi

Honored to participate in the recently published method paper presenting the technical characteristics of novel ELISA assays measuring C-peptide and all six proglucagon-derived peptides (i.e., GLP-1, GLP-2, oxyntomodulin, glicentin, glucagon, major proglucagon fragment-MPGF).

Read the full article here.

Angeliki Angelidi
Previous

Our article selected for Endocrine Society Thematic Issue on Obesity 2022
Next

The effect of dietary patterns on NAFLD diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials and post hoc meta-analysis